Blog - Spirographic AI

Drug Repurposing & Safety | Precision Pharmacology & AI

First Commercial Platform to Predict Albumin Binding Site Specificity
BySpirographicAI April 24, 2026April 24, 2026

Spirographic AI Becomes First Commercial Platform to Predict Albumin Binding Site Specificity — Achieving 86.4% Accuracy Across 198 Drugs Every existing commercial tool predicts only binary bound/unbound status. spirographic AI predicts which site — Site I, Site II, or Subdomain IB — with 93.8% sensitivity for high binders, from SMILES input alone. CORVALLIS, Ore., April 23,…

Read More First Commercial Platform to Predict Albumin Binding Site Specificity
Precision Pharmacology & AI | Tissue-Specific Insights

Tissue-Specific Polypharmacology Platform
BySpirographicAI April 14, 2026April 24, 2026

Our tissue-specific polypharmacology prediction platform, demonstrating breakthrough performance in pharmaceutical drug target identification and side effect prediction across 200 compounds and 195 biological receptors spanning 8 organ systems.

Read More Tissue-Specific Polypharmacology Platform
Drug Repurposing & Safety

Predict Drug Exposure in Fetal and Breast Milk
BySpirographicAI April 7, 2026April 14, 2026

Spirographic AI, LLC today announced commercial availability of two proprietary prediction engines covering two of the most clinically sensitive pharmacokinetic compartments in medicine: the placental barrier and the mammary epithelium.

Read More Predict Drug Exposure in Fetal and Breast Milk